Title
Sun Life of Canada , Inc. vs. Sibya
Case
G.R. No. 211212
Decision Date
Jun 8, 2016
Insured disclosed 1987 kidney treatment; Sun Life denied claim citing undisclosed 1994 treatment. SC ruled no concealment, upheld incontestability clause, ordered death benefits paid.
insurer
death benefits
damages
A

Case Summary (G.R. No. 211212)

Key Dates and Places

Policy issued: February 5, 2001 (Insurance Policy No. 031097335).
Death of insured: May 11, 2001 (gunshot wound in San Joaquin, Iloilo).
RTC decision: March 16, 2009 (dismissing insurer’s rescission action; awarding benefits and damages).
CA decision: November 18, 2013 (affirming award of benefits and damages; absolving insurer from violations of Sections 241 and 242 of the Insurance Code).
Supreme Court decision: June 8, 2016 (petition denied; CA decision affirmed).

Applicable Law and Authorities

Governing constitution: 1987 Philippine Constitution (applicable as decision date is post-1990).
Statutory provisions cited: Presidential Decree No. 612 (Insurance Code), specifically Sections 241 (unfair claim settlement practices) and 242 (time for payment of life insurance proceeds).
Procedural rule: Rule 45, Rules of Court (petition for review on certiorari).
Controlling jurisprudence cited: Manila Bankers Life Insurance Corp. v. Aban (715 Phil. 404, 2013) on the incontestability principle; Philamcare Health Systems, Inc. v. CA (429 Phil. 82, 2002) on insurer’s burden to prove concealment; Spouses Bernales v. Heirs of Julian Sambaan (624 Phil. 88, 2010) on the respect due to factual findings of lower courts.

Factual Background

On January 10, 2001, Atty. Jesus S. Sibya, Jr. completed an application for life insurance with Sun Life, disclosing prior kidney-related treatment and specifying: “Last 1987, had undergone lithotripsy due to kidney stone under Dr. Jesus Benjamin Mendoza at National Kidney Institute, discharged after 3 days, no recurrence as claimed.” Sun Life issued the policy on February 5, 2001. The insured died on May 11, 2001 from a gunshot wound. Respondents filed a claim for the P1,000,000.00 death benefit. Sun Life denied the claim on August 27, 2001, alleging nondisclosure of medical history (specifically treatments at the National Kidney Transplant Institute in May and August 1994) and tendered a refund of premiums. Sun Life then filed a Complaint for Rescission in the RTC seeking judicial confirmation of rescission. Respondents defended, asserting no material misrepresentation and that the insured had in fact authorized Sun Life to investigate his medical history.

Procedural Posture

The RTC dismissed Sun Life’s complaint and ordered payment of the death benefit and damages (P1,000,000.00 death benefit; P100,000.00 moral damages; P100,000.00 exemplary damages; P100,000.00 attorney’s fees and costs). The CA affirmed the RTC’s award of benefits and damages but modified the RTC’s ruling by absolving Sun Life from violations of Sections 241 and 242 of the Insurance Code. Sun Life sought Supreme Court review via Rule 45; the Supreme Court denied the petition and affirmed the CA decision.

Issue Presented

Whether the Court of Appeals erred in affirming the RTC’s finding that the insured did not commit concealment or misrepresentation in his insurance application, thereby entitling the respondents to the policy proceeds and damages.

Supreme Court’s Analysis — Incontestability and Its Application

The Supreme Court applied the incontestability principle as articulated in Manila Bankers Life Insurance Corp. v. Aban: an insurer has two years from the effectivity of a life insurance contract—while the insured is alive—to discover or prove that the policy is voidable for fraudulent concealment or misrepresentation. If the insured dies within that two-year contestability period, the insurer’s right to rescind becomes unenforceable and the insurer must pay the policy proceeds even if the policy was obtained by fraud. In the present case, the policy was issued on February 5, 2001 and the insured died on May 11, 2001, three months later, i.e., within the two-year period; thus the insurer lost the right to rescind and became bound to pay under the policy.

Supreme Court’s Alternative Analysis — Lack of Proved Concealment or Fraudulent Intent

The Court further addressed the matter on the merits in the alternative: even assuming contestability had not been triggered, Sun Life failed to establish concealment or misrepresentation. The insured had expressly disclosed prior kidney treatment in the application, including year (1987), procedure (lithotripsy), length of confinement (3 days), attending physician, and hospital. He also signed an authorization permitting Sun Life to obtain his medical records. The CA found, and the Supreme Court agreed, that the insured’s statement “no recurrence” could be an honest opinion by a non-medical applicant and that, given the authorization, Sun Life had the means to investigate. The Court reiterated the well-established rule that concealment is an affirmative defense requiring the insurer to prove intent to deceive by satisfactory and convincing evidence; Sun Life did not me

...continue reading

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.

About Privacy Terms